Raytheon Technologies WKN: A2PZ0R ISIN: US75513E1010 Kürzel: RTX Forum: Aktien User: KlabusterKlaus

Es gab eine Fusion mit utc

Hab mal eine kleine Position nachgekauft. EK jetzt bei ~50€, das lass ich jetzt so ein paar Jährchen liegen.

Wieso fällt der Kurs denn so stark??

Da wird verkauft, weil man die Erwartungen übertrifft, aber das hier noch wahnsinnig viel potential ist...Verstehe wer will, Sparplan freut es leider nicht, das war am 23...

👍

Wer hier um die 48/49 Euro eingestiegen ist, für den lohnt sich das Halten der Aktie auf jeden Fall.

Hier geht gar nichts.

Ist solide und ich sehe das auch so.

Hallo, habe hier seit Juni einen Sparplan laufen, mit anderen gebeutelten Werten der Luft und Reisebranche. Denke mit einem langen Horizont. Erholung 2 Jahre, neue hochs 3 bis 5 jahre sollte man von den niedrigen EK profitieren. Mutig ja, aber war und ist ein solides Unternehmen. Wünsche uns allen bessere Kurse!

Hier ist die Erklärung fűr den Kursanstieg: Raytheon Technologies (RTX +3.5%) plans to cut 15K jobs, nearly twice as many as previously anticipated, saying the commercial aerospace market will take several years to recover from the pandemic. The reduced payroll is part of a push to cut $2B in costs this year and save $4B in cash as COVID-19 crushes air travel and saps demand for new planes, CEO Greg Hayes said today at a Morgan Stanley conference. "We see a gradual return to flight across all commercial markets but probably not a full return to 2019 levels until somewhere around 2023," Hayes said, adding the timing depends on the timing of a vaccine.

Raytheon Technologies (RTX -2.6%) has scored a $579.8M deal that provides unit and depot level F-135 propulsion system spare parts, spare engines and modules in support of the F-135, an afterburning turbofan that powers all three variants of the F-35 Lightning II. Included in the contract are propulsion initial spares requirements for the Air Force, Navy, Marine Corps, non-Department of Defense participants and Foreign Military Sales customers. The majority of the work will be performed in East Hartford, Connecticut, and is expected to be completed in December 2024. Funds will be obligated on individual orders as they are issued. "Investors should continue holding Raytheon for the dividend income and the potential for a strong rebound," writes Chris Lau in a SA article

Don’t cry for 3 Dow Jones leavers; stocks tend to hold up Aug. 25, 2020 12:11 PM ETExxon Mobil Corporation (XOM)By: Kim Khan, SA News Editor42 Comments Being replaced in the Dow may just amount to a bruised ego. Exxon Mobil (XOM, -2.9%), Raytheon (RTX, -3.1%) and Pfizer (PFE, -1.6%) are all struggling today as the stocks were shown the door from the Dow Jones Industrial Average. The general thinking is that the stocks will lose the support of money indexed or benchmarked to the Dow. It’s more likely just a knee-jerk reaction to a negative headline, though. Yes, there is $28B indexed to the Dow 30. But there’s $11.2T indexed and benchmarked to the S&P, with index funds making up $4.6T. In fact, the effect of losing Dow status may just be hurt pride. Looking further down the road, getting jettisoned from the index doesn’t seem to have much impact on shares.  Of the 17 stocks that have been removed from the Dow since 1999, the average one-year performance is down less than 1%, according to WSJ Market Data Group calculated in mid-2018. The last big Dow reshuffle in 2013 saw Alcoa (AA, -1.5%), Bank of America (BAC, +0.8%) and Hewlett-Packard leave. A year later, Alcoa was up 96%, BofA was up 17% and HP was up 73%. How did Exxon, Pfizer and Raytheon get the boot? The main reason is that S&P Dow Jones Indices wants to pivot the index more to tech and it would be losing a lot of that exposure after Apple’s stock split, since the Dow is a price-weighted index. Exxon has been a member of the index since 1928. But over the last 10 years, Exxon is down 28.4%, compared with fellow Dow member Chevron, up 18.2%. Looking at total return, Exxon is up just 2.3%, with Chevron up 73.7%. Pfizer has performed about the same as fellow component Merck (MRK, -0.1%) in the last 10 years, both up about 250%. Replacement Amgen (AMGN, +4%) is up 466%. But in the last five years, Merck, up 94%, has nearly doubled the performance of Pfizer, up 49%. Raytheon is simply not the company is was when it was just United Technologies, with much more aerospace exposure, already featuring in the index with Boeing (BA, -2.8%). Honeywell (HON, +3%), ousted in 2008, brings back more of the pure industrial business. Investors should perhaps be more concerned about the shares of new entries. According to the same data cited earlier, the 17 new entrants since 1999 fell 8% on average a year after their Dow debut.  Walgreens (WBA, -1.4%) is down 42% since it entered the index in 2018.

Dito

Überlege mit einer kleinen Position einzusteigen

Wieso Katastrophe? Bei so einem Unternehmen positioniert man sich genau jetzt und muss eben in Kauf nehmen dass es noch weiter absackt. Das ist ein langfristiger Kauf und man braucht Geduld. In 3-5 Jahren werden wir deutlich höher stehen. Homm hat ja hier auch nur eine ganz kleine Position und so halte ich es auch.

I am sure many of you are wondering why is the stock price down if the Q2 beat was very good. This was a great Quarter given what is happening in the Aerospace industry the reason RTX is trading down today is because the Q2 Beat was driven by implimented cost cutting measures rather then organic profit growth but CEO Greg Hayes nailed the Quarter. AS stated by CEO Greg Hayes "The RTX balance sheet remains strong and the resiliency of our defense business will help RTX weather this storm as we continue to capitalize on growth opportunities supported by our record backlog. I am confident that our balanced portfolio and advanced technologies will position us for long-term value creation as the global economy recovers."